Sumitomo Pharma Co., Ltd.
4506.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥679,763 | ¥385,769 | ¥289,624 | ¥223,674 |
| - Cash | ¥38,490 | ¥20,453 | ¥23,116 | ¥85,393 |
| + Debt | ¥262,850 | ¥309,245 | ¥305,422 | ¥374,423 |
| Enterprise Value | ¥904,123 | ¥674,561 | ¥571,930 | ¥512,704 |
| Revenue | ¥119,120 | ¥108,002 | ¥105,649 | ¥112,434 |
| % Growth | 10.3% | 2.2% | -6% | – |
| Gross Profit | ¥73,531 | ¥63,890 | ¥65,978 | ¥70,995 |
| % Margin | 61.7% | 59.2% | 62.5% | 63.1% |
| EBITDA | ¥86,148 | ¥26,188 | ¥5,604 | ¥27,471 |
| % Margin | 72.3% | 24.2% | 5.3% | 24.4% |
| Net Income | ¥87,654 | ¥11,206 | ¥2,415 | ¥53,448 |
| % Margin | 73.6% | 10.4% | 2.3% | 47.5% |
| EPS Diluted | 220.63 | 28.21 | 6.08 | 134.53 |
| % Growth | 682.1% | 364% | -95.5% | – |
| Operating Cash Flow | ¥18,217 | -¥192 | ¥11,009 | ¥939 |
| Capital Expenditures | -¥1,049 | -¥1,474 | -¥2,375 | -¥2,057 |
| Free Cash Flow | ¥17,168 | -¥1,666 | ¥8,634 | -¥1,118 |